Dr. Deepak Behera is no stranger to the puzzles of radiopharmaceutical development and life sciences marketing. That’s why, on this episode of Fractals: The Life Sciences Questionnaire, he shared his perspectives on holistic clinical development strategies and the importance of breaking siloed communication, as well as: 

• Why pairing the needs of patients with clinical development strategy is essential for driving positive health outcomes
• Diversifying accessibility to clinical trials through community physician and hospital participation
• Integrated approaches to marketing and business strategy, and risk mitigation
• Breaking barriers in clinical development, and the importance of soft skills

Brad Wyman’s seen a few things over his 30-year career: the potential of medical imaging, the limits of biomarker development, and the struggles and successes inherent to translational medicine. Join host Colin Miller as Brad shares stories from the front lines of clinical development. 

• Why successful biomarkers don’t guarantee clinical success
• Engineers vs. scientists, and how Brad distinguishes between them 
• Integrated approaches to marketing and business strategy
• The impact of AI, and where Brad would invest a hypothetical $100M (hint: it’s not AI)

With 50+ M&A deals to her name, Dawn Flitcraft knows what it takes to bring successful deals home, and spot problematic projects early on. Join host Colin Miller as Dawn serves as our Aristotle through the ethical landscape of M&A, with valuable takeaways at every turn:

• 4 key components of successful (and unsuccessful!) deals
• Principles for effective post-deal marketing
• Steering executive teams through M&A
• When emotion becomes an “X” factor
• Operation Warp Speed and Dawn’s time leading ethical review at WCG IRB